# Takeda Commits Up to $1.7 Billion to Iambic Therapeutics AI-Driven Drug Discovery Platform

> partnership · REPORTED · 2026-06-01

Takeda committed up to $1.7 billion to Iambic Therapeutics for access to its deep learning-powered drug discovery platform, one of the largest pharma-AI collaboration deals announced in 2026. This deal is part of a broader trend of pharma-AI co-investment becoming the dominant operating model in drug development.

- Company: Iambic Therapeutics / Takeda
- Sector: biotech
- Primary source: https://gohub.vc/digital-health-funding-2026/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.